Aakaar Medical Technologies Ltd (AAKAAR) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: AAKAAR | Trading | Small Cap

BSE Share Price
Not Listed

Aakaar Medical Technologies Ltd (AAKAAR) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 0 | NSE: AAKAAR | Trading | Small Cap

DeciZen - make an informed investing decision on Aakaar Medical Techn

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Aakaar Medical Technologies stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
17.58
Market Cap:
106.2 Cr.
52-wk low:
0
52-wk high:
0

Is Aakaar Medical Technologies Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Aakaar Medical Techn: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Aakaar Medical Technologies Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 20.4%25.8%23.3%26.6%-
Value Creation
Index
0.50.80.70.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 19.532.846.161.662
Sales YoY Gr.-68.4%40.7%33.6%-
Adj EPS 1.72.335.74.3
YoY Gr.-37.5%28.1%92.6%-
BVPS (₹) 8.410.113.122.319
Adj Net
Profit
1.62.22.866
Cash Flow from Ops. 0.5-2.9-8-5.4-
Debt/CF from Ops. 7.9-2-1.9-4.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA46.8%33.6%
Adj EPS NANA50.3%92.6%
BVPSNANA38.4%69.8%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
202525.533.320.6
Op. Profit
Mgn %
12.31110.815.8NAN
Net Profit
Mgn %
8.26.76.19.79.8
Debt to
Equity
0.50.61.21-
Working Cap
Days
02102242490
Cash Conv.
Cycle
01641851950

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Aakaar Medical Technologies Ltd.

Standalone Consolidated
TTM EPS (₹) 4.3 -
TTM Sales (₹ Cr.) 61.6 -
BVPS (₹.) 19 -
Reserves (₹ Cr.) 13 -
P/BV 3.94 -
PE 17.58 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 106
Equity (₹ Cr.) 14.2
Face Value (₹) 10
Industry PE 36.9

Management X-Ray of Aakaar Medical Techn:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Aakaar Medical Techn - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Aakaar Medical Techn

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Sales19334662
Operating Expenses 17294152
Manufacturing Costs0011
Material Costs9152126
Employee Cost 581013
Other Costs 36912
Operating Profit 24510
Operating Profit Margin (%) 12.3%10.8%10.8%15.8%
Other Income 0000
Interest 0012
Depreciation 0000
Exceptional Items 0000
Profit Before Tax 2348
Tax 1112
Profit After Tax 2236
PAT Margin (%) 8.3%6.6%6.2%9.8%
Adjusted EPS (₹)1.72.33.05.8
Dividend Payout Ratio (%)35%24%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 8101323
Share Capital 11110
Reserves 791213
Minority Interest0000
Debt461523
Long Term Debt0000
Short Term Debt461523
Trade Payables2324
Others Liabilities 4556
Total Liabilities 18233556

Fixed Assets

Gross Block0011
Accumulated Depreciation0000
Net Fixed Assets 0000
CWIP 0000
Investments 0000
Inventories7111415
Trade Receivables6101628
Cash Equivalents 2006
Others Assets 3147
Total Assets 18233556

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 0-3-8-5
PBT 2348
Adjustment 0112
Changes in Working Capital -1-6-12-13
Tax Paid -1-1-1-2
Cash Flow From Investing Activity -0-0-0-0
Capex -0-0-0-0
Net Investments -0-0-00
Others 0000
Cash Flow From Financing Activity -11811
Net Proceeds from Shares 0005
Net Proceeds from Borrowing 0000
Interest Paid -0-0-1-2
Dividend Paid -1-100
Others -0297
Net Cash Flow -1-205

Finance Ratio

PARTICULARSMar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)20.1624.3525.8833.81
ROCE (%)20.425.8123.2926.62
Asset Turnover Ratio1.091.611.61.36
PAT to CFO Conversion(x)0-1.5-2.67-0.83
Working Capital Days
Receivable Days10488105131
Inventory Days13110210185
Payable Days65503837

Aakaar Medical Technologies Ltd Stock News

Aakaar Medical Technologies Ltd FAQs

The current trading price of Aakaar Medical Techn on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Aakaar Medical Techn stood at ₹106.2.
The latest P/E ratio of Aakaar Medical Techn as of 31-Dec-1969 is 17.58.
The latest P/B ratio of Aakaar Medical Techn as of 31-Dec-1969 is 3.94.
The 52-week high of Aakaar Medical Techn is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aakaar Medical Techn is ₹61.58 ( Cr.) .

About Aakaar Medical Technologies Ltd

Aakaar Medical Technologies Limited was originally incorporated as ‘Aakaar Medical Technologies Private Limited’, a private limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated June 20, 2013 issued by the Registrar of Companies, Mumbai. Subsequently, the company was converted into a public limited company pursuant to a resolution passed by its shareholders at an extraordinary general meeting held on July 19, 2024 and a fresh certificate of incorporation dated November 18, 2024 was issued by the Registrar of Companies, Mumbai, recording the change in the name of the company from ‘Aakaar Medical Technologies’ to ‘Aakaar Medical Technologies’.

The company is a medical aesthetic company dealing in a wide range of aesthetics & specialized cosmetic products & devices. Its product range includes both Own brands (domestically manufactured products & internationally manufactured devices) and Imported Brands (distribution of imported brands) from countries such as Korea, Spain, Italy, and Austria. It is established a distinctive presence in the medical aesthetic market by exclusively focusing on business-to-business (B2B) channels for product distribution and sales. It supplies its products & devices primarily to dermatologists, plastic surgeons, aesthetic physicians who then sell these products to their end consumers as well as use certain device consumables as part of their treatments. It derives majority of its revenue from Aesthetic products and will continue to focus on its Aesthetic products pipeline.

Business area of the company

Aakaar Medical Technologies is a medical aesthetic company dealing in a wide range of aesthetics & specialised cosmetic products & devices.

Products of the company

  • Injectables & Contouring products
  • Professional Hair & Skin Care products
  • Professional Skin Care products
  • Aesthetic Device products
  • Home Care for Skin products

Awards, accreditations or recognitions

  • 2024: Excellence in Aesthetic Innovation & Service at Starz of India 2024.
  • 2019: Best New Launched Doctor Prescribed Skin Care Cosmetic Range in India for Tubelite Brand Aakaar at GEA Awards 2019.

History and milestones

  • July 21, 2017: Launched its own brand Balback.
  • April 1, 2018: Entered into a tripartite agreement with ACPL and Croma Pharma GmbH for launch of Saypha filler (earlier known as Princess).
  • December 9, 2017: Launched its own brand Lytec.
  • Ocotber 27, 2022: Launched its own brand Etrelume.
  • August 3, 2023: Launched its own brand Swyada.
  • April 01, 2023: Entered into exclusive agreement in licensing, marketing and distribution with Regenera Activa Worldwide S.L for launch of Regenera ActivaAMT.
  • July 21, 2023: Entered into exclusive agreement in licensing, marketing and distribution with Tesslift Co. Limited.
  • August 6, 2024: Launched its own brand Exoluxe and DRS1512.
  • September 2, 2024: Launched its Own brand Eoluxe.
  • November 18, 2024: Conversion of the Company from a private limited company to a public limited company.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×